Financial Year |
March 31 2023 |
Monetary Funds |
648,542,353.80 |
Held-for-trading Financial Assets |
334,873,708.34 |
Notes Receivable |
428,741,430.15 |
Accounts Receivable |
2,999,703,863.15 |
Advances to Suppliers |
41,413,493.89 |
Other Receivables |
5,664,612.63 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,669,941,514.83 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
173,838,909.70 |
Total Current Assets |
7,389,926,326.38 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
151,968,539.23 |
Fixed Assetes |
3,218,306,297.57 |
Under-construction Projects |
312,556,218.52 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
1,429,867,269.75 |
R&D expenses |
516,947,272.68 |
Goodwill |
517,770,364.06 |
Long-Term Deferred and Prepaid Expenses |
4,745,112.12 |
Deferred Income Tax Assets |
98,019,939.32 |
Other Non-Current Assets |
59,065,582.39 |
Sub-Total of Non-Current Assets |
6,388,529,029.15 |
Total Assets |
13,778,455,355.53 |
Short-Term Loans |
674,334,671.05 |
Trading Financial liabilities |
-- |
Notes Payable |
3,100,483,676.70 |
Accounts Payable |
3,447,413,688.93 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
11,030,937.26 |
Taxes Payable |
36,754,942.49 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
487,365,863.47 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
198,062,401.70 |
Other Current Liabilities |
6,394,107.53 |
Sub-Total of Current Liabilities |
7,998,038,318.54 |
Long-term Loans |
1,146,418,316.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
8,071,975.95 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,419,869,127.84 |
Total Liabilities |
9,417,907,446.38 |
Paid-In Capital(Or Share Stock) |
1,970,800,857.00 |
Capital Surplus |
2,280,153,533.63 |
Surplus Reserve |
384,025,435.91 |
LESS:Treasury Stock |
77,830,381.86 |
Undistributed Profits |
-247,113,579.56 |
Minority Stockholder's Interest |
30,850,973.69 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,329,696,935.46 |
Owner's Equity(Stockholder's Equity) |
4,360,547,909.15 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
13,778,455,355.53 |